Business

Result of Retail Offer

Result of Retail Offer.

articleSkinbiotherapeutics PlcNovember 21, 20233/company/skinbiotherapeutics-plc/news/result-of-retail-offer-36
Result of Retail Offer

About this update from Skinbiotherapeutics Plc

[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY UK MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.\n \n \n \n21 November 2023\n \nSkinBioTherapeutics plc\n \n(\"SkinBioTherapeutics\" or the \"Company\")\n \nResult of Retail Offer\n \n \nFurther to the announcement dated 16 November 2023, SkinBioTherapeutics plc (AIM: SBTX or the \"Company\") a life sciences company focused on skin health, is pleased to announce that, following the closing of the Retail Offer on the BookBuild platform on 20 November 2023, 1,315,789 Ordinary Shares will be issued at the Issue Price of 19 pence per Retail Offer Share in connection with the Retail Offer, raising an additional £0.25 million.\n \nAs the Retail Offer was heavily oversubscribed, allocation was made to existing Shareholders applying the principles of soft pre-emption. Shareholders were allocated 100% of their soft pre-emptive allowance. Where the order was greater than the soft pre-emptive allowance shareholders received c.37% of their additional demand. (1)\n \nConsequently, 15,908,298 Placing Shares and 1,315,789 Retail Offer Shares, resulting in a total of 17,224,087 new Ordinary Shares, will be issued in relation to the Placing and Retail Offer, raising total gross proceeds of £3.3 million.\n \nApplication has been made for the Retail Offer Shares to be admitted ...

More updates from Skinbiotherapeutics Plc